Experimental Neurotherapeutics : Surfing the Tidal Wave of New Opportunities
The subspecialty of experimental neurotherapeutics trains neurologists in discovering and developing new treatments for neurologic diseases. Based on development of exciting new treatments for genetic and inflammatory diseases, we predict that there will be many other breakthroughs. The job market has expanded rapidly in academia, the pharmaceutical industry, government, and not‐for‐profit sectors; many new opportunities can be anticipated. The burgeoning opportunities in the field mandate that training address the challenges of overcoming obstacles in therapeutic discovery, implementation science, and development of affordable and equitably available treatments. ANN NEUROL 2023;93:427–430.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:93 |
|---|---|
| Enthalten in: |
Annals of Neurology - 93(2023), 3, Seite 427-430 |
| Beteiligte Personen: |
Reoma, Lauren B. [VerfasserIn] |
|---|
| Anmerkungen: |
© 2023 American Neurological Association |
|---|
| Umfang: |
4 |
|---|
| doi: |
10.1002/ana.26582 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
WLY014968487 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | WLY014968487 | ||
| 003 | DE-627 | ||
| 005 | 20231111123600.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231111s2023 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1002/ana.26582 |2 doi | |
| 028 | 5 | 2 | |a 2023-11-11_ANA_2023_93_3.zip.xml |
| 035 | |a (DE-627)WLY014968487 | ||
| 035 | |a (WILEY)ANA26582 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 100 | 1 | |a Reoma, Lauren B. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Experimental Neurotherapeutics |b Surfing the Tidal Wave of New Opportunities |
| 264 | 1 | |c 2023 | |
| 300 | |a 4 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © 2023 American Neurological Association | ||
| 520 | |a The subspecialty of experimental neurotherapeutics trains neurologists in discovering and developing new treatments for neurologic diseases. Based on development of exciting new treatments for genetic and inflammatory diseases, we predict that there will be many other breakthroughs. The job market has expanded rapidly in academia, the pharmaceutical industry, government, and not‐for‐profit sectors; many new opportunities can be anticipated. The burgeoning opportunities in the field mandate that training address the challenges of overcoming obstacles in therapeutic discovery, implementation science, and development of affordable and equitably available treatments. ANN NEUROL 2023;93:427–430 | ||
| 700 | 1 | |a Busza, Ania |4 aut | |
| 700 | 1 | |a Mouradian, M. Maral |4 aut | |
| 700 | 1 | |a Kaufmann, Petra |4 aut | |
| 700 | 1 | |a Augustine, Erika F. |4 aut | |
| 700 | 1 | |a Frank, Samuel |4 aut | |
| 700 | 1 | |a Sutula, Thomas P. |4 aut | |
| 700 | 1 | |a Cole, Andrew J. |4 aut | |
| 700 | 1 | |a Fitter, Heather D. |4 aut | |
| 700 | 1 | |a Meurer, William |4 aut | |
| 700 | 1 | |a Nath, Avindra |4 aut | |
| 700 | 1 | |a Griggs, Robert C. |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of Neurology |g 93(2023), 3, Seite 427-430 |w (DE-627)WLY001695479 |x 15318249 |7 nnns |
| 773 | 1 | 8 | |g volume:93 |g year:2023 |g number:3 |g pages:427-430 |g extent:4 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_WLY | ||
| 951 | |a AR | ||
| 952 | |d 93 |j 2023 |e 3 |h 427-430 |g 4 | ||